No evidence for core-binding factor CBFβ as a leukemia predisposing factor in chromosome 16q22-linked familial AML

This publication has 7 references indexed in Scilit:

• AML1 Interconnected Pathways of Leukemogenesis
  Cancer Investigation, 2003
• Unlike AML1, CBFβ gene is not deregulated by point mutations in acute myeloid leukemia and in myelodysplastic syndromes
  Blood, 2002
• In vitro analyses of known and novel RUNX1/AML1 mutations in dominant familial platelet disorder with predisposition to acute myelogenous leukemia: implications for mechanisms of pathogenesis
  Blood, 2002
• Transcription factors and translocations in lymphoid and myeloid leukemia
  Leukemia, 2001
• Susceptibility gene for familial acute myeloid leukemia associated with loss of 5q and/or 7q is not localized on the commonly deleted portion of 5q
  Genes, Chromosomes and Cancer, 2000
• Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia
  Nature Genetics, 1999
• Genetic Heterogeneity in Familial Acute Myelogenous Leukemia: Evidence for a Second Locus at Chromosome 16q21-23.2
  American Journal of Human Genetics, 1997